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Intracellular bacterial pathogens of a diverse nature
share the ability to evade host immunity by impairing
trafficking of endocytic cargo to lysosomes for
degradation, a process that is poorly understood.
Here, we show that the Salmonella enterica type 3
secreted effector SopD2 mediates this process by
binding the host regulatory GTPase Rab7 and inhib-
iting its nucleotide exchange. Consequently, this
limits Rab7 interaction with its dynein- and kinesin-
binding effectors RILP and FYCO1 and thereby dis-
rupts host-driven regulation of microtubule motors.
Our study identifies a bacterial effector capable of
directly binding and thereby modulating Rab7 activ-
ity and a mechanism of endocytic trafficking disrup-
tion that may provide insight into the pathogenesis of
other bacteria. Additionally, we provide a powerful
tool for the study of Rab7 function, and a potential
therapeutic target.INTRODUCTION
The pathogen Salmonella enterica serovar Typhimurium (S. Ty-
phimurium), a model organism for the study of bacterial path-
ogenesis, is a significant cause of foodborne gastroenteritis
and a causative agent of reactive arthritis (Mead et al., 1999;
Yu and Kuipers, 2003). Upon infection, these bacteria invade
host cells and reside within membrane-bound Salmonella-con-
taining vacuoles (SCVs), which subsequently undergo interac-
tions with the endocytic pathway. The pathogen, however, is
able to manipulate the maturation of SCVs, limiting interactions
with lysosomes and ultimately contributing to the establish-
ment of a replicative niche in host cells (Brumell and Grinstein,
2004).1508 Cell Reports 12, 1508–1518, September 1, 2015 ª2015 The AuHost cell manipulation is mediated by an arsenal of over 30
virulence proteins called effectors (Figueira and Holden,
2012), which are delivered to the host cell cytosol by two inde-
pendent type 3 secretion systems (T3SSs), encoded by Salmo-
nella pathogenicity island (SPI)-1 and SPI-2. Effectors of the
SPI-1 T3SS facilitate bacterial invasion. Subsequently, SPI-2
T3SS effectors mediate processes that promote bacterial sur-
vival and replication within SCVs (Brumell and Grinstein,
2004). Among the most prominent yet poorly understood con-
sequences of host cell manipulation by Salmonella and other
clinically relevant pathogens is the sustained perturbation of
lysosomal function (Buchmeier and Heffron, 1991; Ishibashi
and Arai, 1990; Lamothe et al., 2007; Seto et al., 2009). Salmo-
nella can cause a global impairment of host endocytic traf-
ficking to lysosomes. This effect is known to be SPI-2 T3SS
dependent (Uchiya et al., 1999; Yu et al., 2002); however, the
effector(s) responsible, the host target, and mechanism of ac-
tion have yet to be elucidated. In this study, we show that
the effector SopD2 is both necessary and sufficient to mediate
this phenotype and that it functions by directly targeting a key
host regulatory GTPase in the endocytic pathway and blocking
its function.
RESULTS
The Effector SopD2 Is Necessary and Sufficient to Block
Endocytic Trafficking
To investigate endocytic progression in host cells during infec-
tion, we used a fluorescence-based assay that monitors a
BODIPY TR-X conjugate of BSA (DQ-Red BSA). Upon delivery
to compartments containing active proteases, this self-
quenched substrate is cleaved, releasing highly fluorescent
peptides. Owing to its broad specificity with respect to lyso-
somal hydrolases, this assay detects global defects in lyso-
some function.
HeLa cells were infected for 8 hr with GFP-expressing wild-
type (WT) Salmonella prior to DQ-Red BSA treatmentthors
Figure 1. The SPI-2 T3SS Effector SopD2 Is Necessary and Sufficient to Block Endocytic Trafficking to Lysosomes
Scale bars, 10 mm. For quantifications, the means ± SEM are shown.
(A) HeLa cells were infected with GFP-expressing S. Typhimurium (green) for 8 hr and then incubated with DQ-Red BSA (red) for 1 hr. Images were acquired after
an additional 4 hr chase.
(B) Quantification of DQ-Red BSA signal for (A).
(C) HeLa cells were transfected with GFP-tagged constructs (green) and then pulsed with DQ-Red BSA (red) and chased as described above.
(D) Quantification of DQ-Red BSA signal for (C).
(E) HeLa cells were transfected with GFP-tagged constructs overnight and then pulsed with BSA-Cy3 for 30 min to assess internalization. Quantification of
BSA-Cy3 intensity.(Figure S1A). Non-infected cells generated bright punctate sig-
nals, whereas intensities from infected cells were significantly
decreased (Figures S1B and S1C). The SPI-2 T3SS-defective
mutant (DssaR) yielded signals equivalent to those emitted by
non-infected cells (Figures S1B and S1C), consistent with find-
ings from previous studies implicating the SPI-2 T3SS (Uchiya
et al., 1999; Yu et al., 2002). Cells infected with WT bacteria
and subsequently exposed to fluorescent BSA-Cy3 exhibited
no difference in probe intensity compared to non-infected cells
(Figures S1D–S1F), suggesting the absence of a defect in
internalization.
The SPI-2 T3SS effector SopD2, previously shown to
contribute to virulence in a murine systemic infection model
(Jiang et al., 2004), localizes to SCVs and late endocytic com-
partments (Brumell et al., 2003; Jiang et al., 2004). HeLa cellsCell Reinfected with Salmonella lacking SopD2 (DsopD2) displayed
DQ-Red BSA fluorescence intensities comparable to non-in-
fected cells (Figures 1A and 1B), suggesting a role for this
effector in blocking delivery of endocytic contents to lyso-
somes. This phenotype was also observed in RAW 264.7 mac-
rophages (Figures S2A and S2B). In contrast, deletion of the
effector SopB, whose activity decreases levels of SCV-lyso-
some fusion at early time points of infection (Bakowski et al.,
2010), or the effector SopD, which shares sequence similarity
with SopD2, had no effect on DQ-Red BSA fluorescence (Fig-
ure 1B). Epithelial cells transfected with GFP-tagged SopD2 ex-
hibited a significant decrease in DQ-Red BSA fluorescence
compared to non-transfected cells (Figures 1C and 1D). This
marked attenuation of signal was specific to SopD2 and was
not observed with GFP alone or GFP-SifA (Figure 1D). SifA isports 12, 1508–1518, September 1, 2015 ª2015 The Authors 1509
Figure 2. Assessment of Cathepsin L Activ-
ity and Endocytic Trafficking in S. Typhimu-
rium-Infected Epithelial Cells
(A) HeLa cells were infected with GFP-expressing
WT S. Typhimurium, the DsopD2 mutant, or the
SPI-2 T3SS mutant (DssaR) (green) for 8 hr prior to
treatment with Magic Red Cathepsin L (Magic Red
CatL, in red).
(B) Quantification of the intensity of the Magic
Red Cathepsin L signal, presented as a percent-
age of control (non-infected cells). Statistical
significance between infected conditions was
calculated using a one-way ANOVA with a Bon-
ferroni post hoc test. N.S. represents not statisti-
cally significant.
(C) HeLa cells were loaded with dextran 647 for
8 hr, transfected with GFP or GFP-SopD2 (green),
and then pulsed with rhodamine dextran for
30min. Imaging was performed after 2 hr of chase.
Mander’s coefficient between dextran derivatives
is shown.
(D) Representative images of dextran 647 pre-
treated cells (blue) transfected with GFP or GFP-
SopD2 (green) prior to rhodamine dextran (red)
treatment. Insets are enlarged from the indicated
area. Arrowheads indicate colocalization between
dextran derivatives in upper panels and absence
of colocalization in lower panels.
Scale bars, 10 mm. For quantifications, the
means ± SEM are shown.a SPI-2 T3SS effector that was recently shown to block M6PR
recycling during infection (McGourty et al., 2012). Our findings
demonstrate that SifA-mediated inhibition of M6PR recycling,
while capable of decreasing cathepsin B activity (McGourty
et al., 2012), is not sufficient to suppress overall lysosome
function.
We used the Magic Red Cathepsin L Assay Kit to monitor
activity of the pH-sensitive protease cathepsin L. This cell-1510 Cell Reports 12, 1508–1518, September 1, 2015 ª2015 The Authorspermeant, substrate-based reagent be-
comes fluorescent upon cleavage. No
significant difference in fluorescence in-
tensities was observed between cells
infected with WT, DsopD2, and DssaR
deletion mutants (Figures 2A and 2B),
suggesting that SopD2 does not affect
total cellular lysosomal protease
activity.
Expression of SopD2 did not alter
internalization of BSA-Cy3 (Figure 1E),
and Salmonella-infected cells simulta-
neously pulsed with DQ-Red BSA and
dextran 647 exhibited similar DQ-Red
BSA fluorescence intensities when cor-
rected for relative dextran levels (Figures
S2C and S2D), ruling out a defect in
internalization. Therefore, we further
investigated delivery of endosomal
cargo to lysosomes. Lysosomes were
pre-loaded with dextran 647 prior totransfection and then treated with rhodamine dextran. In
GFP-expressing cells, the dextran derivatives colocalized with
a Mander’s coefficient of more than 0.5, indicating significant
endosome-lysosome fusion, whereas GFP-SopD2 expression
resulted in significantly less colocalization (Figures 2C and
2D). Collectively, these observations demonstrate that SopD2
is both necessary and sufficient to impair endocytic trafficking
by blocking delivery of endocytic contents to lysosomes.
Figure 3. The Amino Terminus of SopD2 Is Sufficient to Inhibit Trafficking to Lysosomes
(A) Superposition of SopD2 (red) and SopD (blue) structures. The regions in dark blue and bright red represent the N-terminal dissimilar regions.
(B) Schematic of S. Typhimurium effector SopD2. Amino acids 31–64 include the WEK(I/M)XXFF motif, which contains the tryptophan (W) and phenylalanine (F)
residues required for membrane targeting. The region of dissimilarity with SopD, as reflected by crystal structure data, is indicated in bright red.
(C) Domain mapping of SopD2 functional region by DQ-Red BSA (red) assay. HeLa cells expressing GFP-SopD2 domain truncations were treated with DQ-Red
BSA as in Figure 1. Scale bars, 10 mm.
(D) Quantification of DQ-Red BSA signal for (C). The means ± SEM are shown.The Amino Terminus of SopD2 Inhibits Trafficking
to Lysosomes
SopD2 is thought to have arisen by gene duplication of the T3SS
effector SopD. The two proteins share 43% sequence identity,
although they appear to target unique processes in host cells
(Brumell et al., 2003). Three-dimensional structures of both ef-
fectors were determined by X-ray crystallography (Figure 3A;
Figure S3; Table S1). The reconstructed amino terminus of
each effector occupied a unique three-dimensional space,
whereas extensive homology was established throughout the
remainder of the peptides. SopD2’s amino-terminal domain me-
diates targeting of the protein to late endocytic compartmentsCell Re(Brown et al., 2006; Brumell et al., 2003) (Figure 3B). Using
GFP-fused truncations of SopD2, we mapped the domain
involved in inhibiting endocytic traffic (Figures 3C and 3D). The
first 150 amino acids inhibited DQ-Red BSA fluorescence in a
manner comparable to full-length SopD2, while smaller trunca-
tions of this region demonstrated a partial effect. In contrast, in-
hibition was not observed with the carboxyl-terminal portion,
which localized to the cytosol.
To assess these findings in the context of infection, we created
a series of constructs in the Salmonella complementation
plasmid pACYC184 representing full-length and N-terminal re-
gions of SopD2 and SopD, as well as chimeric proteinsports 12, 1508–1518, September 1, 2015 ª2015 The Authors 1511
(legend on next page)
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(Figure 5A). These constructs were introduced into the DsopD2
Salmonella strain and used in infection-based DQ-Red BSA as-
says. Only infection with Salmonella expressing full-length
SopD2, its first 150 amino acids, and the chimeric effector con-
taining the N-terminal region of SopD2 exhibited decreased
fluorescence intensities (Figure 5B). Collectively, these results
indicate that amino terminus of SopD2 inhibits trafficking to lyso-
somes and that this region diverged from its related effector
SopD, both structurally and functionally.
SopD2 Disrupts Rab7 Function by Impairing
Recruitment of Its Effectors
SopD2 targets to late endocytic compartmentswhere it co-local-
izeswith the small GTPaseRab7 (Brumell et al., 2003) (Figure 4A),
previously shown to regulate endocytic traffic and mediate the
delivery of endosomal contents to lysosomes (Cantalupo et al.,
2001; Feng et al., 1995; Me´resse et al., 1995; Progida et al.,
2007). Therefore, we hypothesized that SopD2 functions by im-
pairing Rab7 activity. Rab7-dependent endocytic trafficking is
mediated by the host effectors RILP (Rab-interacting lysosomal
protein) and FYCO1 (FYVE and coiled-coil domain containing
protein 1), which are recruited from the cytosol by active (GTP-
bound) Rab7 (Cantalupo et al., 2001; Pankiv et al., 2010). This
binding promotes recruitment of dynein/dynactin and kinesin,
facilitatingminus-end- andplus-end-directed vesiclemovement,
respectively, along microtubules (Jordens et al., 2001; Pankiv
et al., 2010). To investigate this process, we used a series of
fluorescent probes to visualize active Rab7. GFP-RILPC33 and
mCherry-FYCO1 localized to LAMP1-positive endocytic com-
partments in transfected cells (Figures 4B and S4B), whereas
siRNA-mediatedRab7 knockdown resulted in their displacement
to the cytosol (Figures S4A, S4D, and S4E). Similarly, cells co-
transfectedwith SopD2 demonstrated a significant relocalization
to the cytosol (Figures 4B, 4C, and S4C), suggesting that SopD2
is sufficient to prevent Rab7’s interaction with its effectors.
Next, we examined the impact of SopD2 on Rab7 activity in
the context of infection. Cells were infected with Salmonella
and transfected with the Rab7 activity probes. SCVs containing
WT bacteria displayed low levels of colocalization with
RILPC33 and FYCO1 (Figures 4D–4G), whereas levels were
significantly higher on SCVs harboring the DsopD2 mutant.
Furthermore, when the DsopD2 Salmonella mutant was used,
only complementation with full-length SopD2, its first 150
amino acids, and the chimeric effector with the N-terminal
region of SopD2 exhibited decreased levels of SCV colocaliza-
tion with RILPC33 (Figure 5C). This demonstrates the impor-
tance of SopD2 in directing vacuolar maturation during infec-
tion and indicates that SopD2 disrupts Rab7 activity byFigure 4. SopD2 Disrupts Rab7 Function by Impairing Recruitment of
(A) HeLa cells were transfected with GFP-Rab7 (green) and RFP-SopD2 (red). Sc
(B) HeLa cells were transfected with GFP-RILPC33 (green) and either RFP or RF
(C) Quantification of the percentage of cells containing cytosolic RILPC33 or FYC
(D–G) HeLa cells were infected withWT S. Typhimurium or the isogenic mutantDs
(F). Cells were fixed at 10 hr post-infection and immunostained. In (D), GFP-RILPC
in blue. In (F), mCherry-FYCO1 is indicated in red, LAMP1 is indicated in green, an
of SCV colocalization with RILPC33 or FYCO1.
For quantifications, the means ± SEM are shown.
Cell Reimpairing its ability to bind its cognate effectors in host cells
during infection.
SopD2 Directly Interacts with Rab7 and Perturbs
Function
To investigate a possible interaction of SopD2 with Rab7,
co-immunoprecipitation experiments were performed using
HEK293T cells expressing Flag-SopD2 and RFP-Rab7. SopD2
was observed to interact with Rab7 (Figure 6A) without a distinct
preference for either the constitutively active (Q67L) or domi-
nant-negative (T22N) variants. Subsequently, the GFP fusions
of SopD2 from Figure 3C were used for domain mapping. By
means of pull-down assays, we found that Rab7 binding is medi-
ated by the N-terminal region of SopD2 (Figure 6B), consistent
with the ability of this region to both inhibit endocytic trafficking
to lysosomes and impair localization of Rab7 effectors RILP and
FYCO1. To examine the nature of this interaction, we reconsti-
tuted binding in vitro with purified proteins. Using nucleotide-
loaded GST-Rab7, we found that the amino terminus of SopD2
preferentially binds Rab7, as compared to its carboxyl terminus,
and that this interaction is direct (Figure 6C). This direct associ-
ation occurred in a manner independent of the activation state of
Rab7, consistent with co-immunoprecipitation studies (Fig-
ure 6A), and was specific for SopD2, as comparable interactions
were not observedwith the amino terminus of SopD or full-length
SifA (Figures 6C and 6D).
The region of interaction between Rab7 and RILP has been
previously established (Wu et al., 2005). This interaction, unlike
that of Rab7 and SopD2, occurs in a nucleotide-dependent
manner. We utilized mutants of Rab7 known to be impaired in
RILP binding (Wu et al., 2005) and assessed their association
with SopD2. Co-immunoprecipitations indicated that no single
mutation in the Rab7 effector-binding domain diminished bind-
ing to SopD2 (Figure 6E). Furthermore, mutation of all four sites
essential for RILP binding was not sufficient to impair SopD2
interaction with Rab7. This suggests that SopD2 and RILP
interact with Rab7 through different binding sites.
To investigate whether SopD2 directly causes RILP displace-
ment from active Rab7, we performed in vitro competitive bind-
ing studies. Regardless of whether Rab7 was preincubated with
SopD2 prior to RILP addition, SopD2 was not sufficient to
decrease RILP binding (Figure 6F). Collectively, these data sug-
gest that, although SopD2 binds Rab7 directly, it does not cause
effector displacement in host cells through a competitive binding
mechanism.
The Salmonella T3SS effector SopB has been shown to inhibit
the host GTPase Cdc42 by limiting its nucleotide exchange ac-
tivity (Burkinshaw et al., 2012). Therefore, we examined Rab7Its Endogenous Effectors
ale bar, 6 mm.
P-SopD2 (red) and were immunostained for LAMP1 (blue). Scale bars, 10 mm.
O1.
opD2 and subsequently transfected with GFP-RILPC33 (D) or mCherry-FYCO1
33 is indicated in green, LAMP1 is indicated in red, and Salmonella is indicated
d Salmonella is indicated in blue. Scale bars, 10 mm. (E) and (G) Quantifications
ports 12, 1508–1518, September 1, 2015 ª2015 The Authors 1513
Figure 5. Salmonella-Induced Suppression of Endocytic Trafficking to Lysosomes and Impairment of Rab7 Function Is Mediated by the
Amino Terminus of SopD2
For quantifications, the means ± SEM are shown.
(A) Schematic of geneproducts of the constructs used for infection-basedcomplementation studies inSalmonella. All constructsweregeneratedusing theplasmid
pACYC184, engineered to contain the promoter region of sopD2. Constructs harbor either full-length effectors, amino-terminal regions, or hybrid effectors.
(B) DQ-Red BSA complementation studies. HeLa cells were infected with GFP-expressing S. Typhimurium strains harboring pACYC184 plasmids for 8 hr and
then incubated with DQ-Red BSA for 1 hr. Images were acquired after an additional 4 hr chase. Quantification of the DQ-Red BSA signal, where the genetic
background of each strain, either DsopD2 or WT SL1344, is indicated on the x axis. Statistical significance of infected versus non-infected populations (indicated
by one asterisk) and among infected conditions (one-way ANOVA with Bonferroni post hoc test; indicated by two asterisks) is shown (p < 0.05).
(C) HeLa cells were infected with S. Typhimurium strains harboring pACYC184 complementation plasmids and then transfected with the Rab7 activity probe
GFP-RILPC33. Cells were fixed at 10 hr post-infection and immunostained. Quantification of SCV colocalizationwith RILPC33 is shown. The p values determined
to be statistically significant (p < 0.05) were calculated using a one-way ANOVAwith Bonferroni post hoc test, and selected comparisons are shown (indicated by
one asterisk).nucleotide exchange using the nucleotide analog N-methylan-
thraniloyl-guanosine diphosphate (Mant-GDP), which fluoresces
optimally when bound to protein. In control experiments, GTP
addition resulted in a decrease in fluorescence as Mant-GDP is
released via nucleotide exchange (Figure 6G). This effect was
suppressed in a dose-dependent manner by SopD2, but not
by BSA.
Our data indicate that SopD2 suppresses Rab7 function on
SCVs and late endocytic compartments, as SopD2 both impairs
Rab7’s ability to recruit its trafficking-related effectors RILP and
FYCO1 and prevents the delivery of endocytic contents to lyso-
somes. We demonstrate that SopD2 directly binds Rab7 in a
manner distinct from that of RILP, suggesting that recruitment
of host effectors is blocked in a non-competitive manner. We
also show that SopD2-mediated Rab7 suppression likely occurs
at the level of nucleotide exchange. While GDP-bound Rab7 is1514 Cell Reports 12, 1508–1518, September 1, 2015 ª2015 The Aunormally maintained in the cytosol (Stenmark, 2009), Rab7 re-
mains colocalized with SopD2 on SCVs and late endocytic
compartments upon inhibition, consistent with a model whereby
SopD2 stabilizes Rab7 on the membrane in its inactive,
GDP-bound form. Therefore, we propose that retention of
Rab7-GDP on the membrane is caused by SopD2 itself. This
would require the bacterial effector to independently associate
with themembrane by a Rab7-independent mechanism. Indeed,
knockdown of Rab7 did not affect SopD2 targeting to these
compartments (Figure S4F).
DISCUSSION
The SPI-2 T3SS effector SopD2 has been shown to contribute to
S. Typhimurium virulence in a murine systemic infection model
(Jiang et al., 2004). Its presence influences the pathogen’s abilitythors
Figure 6. SopD2 Binds to Rab7 and Inhibits Nucleotide Exchange
(A) Co-immunoprecipitations. HEK293T cells were co-transfected with Flag-SopD2 and RFP-Rab7 variants, and lysates were precipitated with anti-FLAG affinity
gel. Elutions were analyzed by western blotting. CA, constitutively active; DN, dominant-negative; RFP, red fluorescent protein.
(B) Pull-down assays. HEK293T cells were transfected with GFP-SopD2 truncations, and lysates were incubated with resin-bound His-Rab7 preloaded with
GTPgS. Elutions were analyzed by western blotting.
(C and D) In vitro binding assays. Rab7-bound resin was preloadedwith GDP or GTPgS and then incubated with purified effector, either full length or the indicated
truncation. Elutions were analyzed by western blotting.
(E) Co-immunoprecipitations. HEK293T cells were co-transfected with Flag-SopD2 and RFP-Rab7 CA, mutated in the RILP-binding region, and lysates were
precipitated with anti-FLAG affinity gel. Elutions were analyzed by western blotting. Sites of point mutations are indicated, and QM indicates a quadruple mutant
(K10A, F45A, D82A, V180A).
(legend continued on next page)
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to replicate in mice (Jiang et al., 2004), and it expresses at high
levels relative to other SPI-2 T3SS effectors using tissue cul-
ture-based infection models (Xu and Hensel, 2010). However
its host target, molecular mechanism, and function in host cells
has been poorly understood. In this study, we establish that
SopD2 plays a key role in bacterial interference with the endo-
cytic pathway. We propose a model in which SopD2 indepen-
dently targets SCVs and late endocytic compartments, stabilizes
Rab7 on these membranes and functions upstream of effector
recruitment to inhibit GTPase cycling (Figure S5A).
Our model suggests several important contributions of SopD2
to Salmonella pathogenesis. By inhibiting Rab7, SopD2 perturbs
endocytic trafficking, contributing to the evasion of lysosomal
degradation of bacteria. Additionally, the displacement of RILP
and FYCO1 on SCVs, as observed in this study, may free host
microtubule motors for hijacking by Salmonella’s dynein- and ki-
nesin-recruiting effectors (Figure S5B), thereby promoting the
formation of Salmonella-induced filaments (Sifs) (Jiang et al.,
2004; Schroeder et al., 2011), elongated LAMP-1-positive mem-
brane extensions (Garcia-del Portillo et al., 1993) that are
thought to play a role in bacterial cell-to-cell spread (Szeto
et al., 2009).
Our study characterizes a bacterial effector that has evolved
the ability to directly bind and inhibit the host GTPase Rab7, a
regulatory switch central to endocytic trafficking, progression,
and, ultimately, lysosome function. While deletion of sopD2 in
Salmonella resulted in a dramatic restoration of trafficking to ly-
sosomes (Figure 1B), it is likely that multiple effectors contribute
to the process of Salmonella-mediated suppression of host lyso-
some function. Indeed, it has been previously shown that SifA
targets the host GTPase Rab9 (Jackson et al., 2008), inhibiting
the process of Rab9-dependent M6PR recycling (McGourty
et al., 2012). Although SifA is not sufficient to perturb overall
levels of lysosome function (Figure 1D), it is capable of impairing
the trafficking of selected lysosomal hydrolytic enzymes
(McGourty et al., 2012). Therefore, S. Typhimurium has evolved
the ability to target two key regulators of late endocytic/lyso-
somal trafficking.
Salmonella can impair adaptive immune responses by disrupt-
ing MHC-II (major histocompatibility complex class II)-associ-
ated antigen presentation in dendritic cells in a SPI-2 T3SS-
dependent manner (Cheminay et al., 2005). SopD2 was among
the effectors implicated in this phenotype (Halici et al., 2008),
and given Rab7’s role in antigen presentation (Bertram et al.,
2002), our data suggest a model whereby SopD2-mediated
disruption of endocytic trafficking impairs antigen presentation.
Therefore, elucidation of SopD2’s function in manipulating
Rab7 activity not only provides a missing link in our understand-
ing of Salmonella’s ability to evade host innate immunity but may
also provide a rationale for this pathogen’s ability to target the
adaptive immune system.
It is also important to note that SopD2 may harbor domains
capable of targeting alternative processes in host cells, as those(F) Competitive in vitro binding assay. Rab7-bound resin, preloaded with GTPg
concentrations of SopD2. Elutions were analyzed by western blotting. The ratio
(G) Nucleotide exchange assay. Rab7was loadedwithMant-GDP. Following desa
the indicated ratios. Reactions were monitored by spectrofluorometry (excitation
1516 Cell Reports 12, 1508–1518, September 1, 2015 ª2015 The Auassociated with Rab7 inhibition appear to be restricted to its
amino-terminal region. Alternately, Salmonellamay use other ef-
fectors to complement SopD2 in the attenuation of Rab7. These
strategies of utilizing multifunctional effectors or multiple effec-
tors with the same GTPase target to manipulate host cell func-
tion are best evidenced by modulation of Rab1 by multiple
type 4 secreted effectors from Legionella pneumophilia (In-
gmundson et al., 2007; Machner and Isberg, 2006, 2007; Mu¨ller
et al., 2010; Murata et al., 2006).
Rab7 is a critical regulatory switch in the endocytic
pathway, playing intrinsic roles in endocytic trafficking and
phagosome-lysosome fusion (Cantalupo et al., 2001; Feng
et al., 1995; Me´resse et al., 1995; Progida et al., 2007). As
such, its inhibition represents an important target of bacte-
rial-mediated pathogenesis, as evidenced by Mycobacterium
tuberculosis and Burkholderia cenocepacia (Huynh et al.,
2010; Seto et al., 2009). Our study identifies the mechanism
of action of a poorly understood bacterial effector, which
directly targets this key endocytic regulator and blocks host
trafficking. These findings provide not only important insight
into the mode of immune evasion by other intracellular patho-
gens but also structural and functional information that may
provide a rationale for both the identification of Rab7-targeting
effectors and the use of SopD2 as a target for therapeutic
strategies.
EXPERIMENTAL PROCEDURES
Cells
HeLa, HEK293T, andRAW264.7 cells were obtained from the ATCC andmain-
tained in growth medium (DMEM high glucose supplemented with 10% fetal
bovine serum [FBS]) without antibiotics. For infections of epithelial cells,
late-log S. Typhimurium cultures were used in amethod optimized for bacterial
invasion (Steele-Mortimer et al., 1999).
DQ-Red-BSA Loading of Live Cells
HeLa cells seeded in eight-well coverglass chambers were either infected
with GFP-expressing S. Typhimurium or transfected. After 8 hr of infection
or 12–16 hr of transfection, cells were incubated for 1 hr in growth medium
containing DQ Red BSA (0.25 mg/ml), washed with PBS, and incubated in
growth medium for 4 hr. For infection of RAW 264.7 mouse macrophages,
cells were treated with DQ Red BSA (10 mg/ml) at 16 hr post-infection.
For additional details, please refer to the Supplemental Experimental
Procedures.
Magic Red Cathepsin L Assay
HeLa cells seeded in eight-well glass-bottom chambers were infected with
GFP-expressing S. Typhimurium. After 8 hr of infection, cells were incubated
for 30 min in growth medium supplemented with Magic Red Cathepsin L
(ImmunoChemistry Technologies, 2.63 concentration).
Confocal Microscopy
When indicated, cells were imaged using a Quorum spinning disk microscope
with a 633 oil immersion objective (Leica DMIRE2 inverted fluorescence
microscope equipped with a Hamamatsu Back-Thinned EM-CCD camera,
spinning disk confocal scan head, and Volocity acquisition software;S, was incubated with equivalent amounts of GST-RILPC33 and increasing
of RILPC33:SopD2 (1:X) is indicated (one asterisk).
lting, exchange reactionswere performed supplementedwith SopD2 or BSA at
at 355 nm, emission at 448 nm).
thors
Improvision). Confocal z-stack images with z steps of 0.3 mm were acquired,
and confocal images were analyzed with Volocity software.
Co-immunoprecipitations
HEK293T cells seeded into 10-cm-diameter tissue culture dishes were co-
transfected with Flag-SopD2 and either pmRFP-N1 or RFP-Rab7 variants.
At 40 hr post-transfection, cells were lysed, and the resulting lysates were
incubated for 2 hr with Anti-FLAG M2 affinity gel. After washing the resin,
bound protein was eluted using 13 SDS-PAGE loading buffer.
In Vitro Binding to Rab7
Recombinant glutathione S-transferase (GST)- and His-tagged proteins, ex-
pressed and purified from E. coli, were used for these studies. Nucleotide
loading of the Rab7 GTPase was performed using a protocol modified
from Jackson et al. (2008), in which His-Rab7 was treated with 0.4 mM
GDP or guanosine triphosphate (GTP)gS. In vitro binding was performed at
4C for 2 hr.
Nucleotide Exchange Assay
Purified untagged Rab7was loaded with 1.5-fold excess of Mant-GDP at room
temperature for 1 hr. The reaction was terminated with 10 mM MgCl2 and de-
salted using a PD-10 column. Exchange reactions contained 22 mM Rab7 in
the presence or absence of SopD2 or BSA. After a 10-min preincubation on
ice, reactions were initiated with 200 mM GTP, and data were acquired at
25C using a microplate spectrofluorometer (excitation at 355 nm, emission
at 448 nm).
Statistics
Three independent experiments were performed, except where indicated, and
the mean ± SEM is shown in the figures. The p values were calculated using a
two-tailed, two-sample, equal-variance Student’s t test, unless otherwise indi-
cated. Where indicated, a one-way ANOVA with Bonferroni post hoc test was
used. A p value < 0.05 was determined to be statistically significant and is indi-
cated by an asterisk in the figures.
ACCESSION NUMBERS
Crystal structure data for SopD2 and SopD have been deposited into the Pro-
tein Data Bank under accession codes 5CQ9 and 5CPC, respectively.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and one table and and can be found with this article online at
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ACKNOWLEDGMENTS
We thank members of the J.H.B. lab for critical reading of this manuscript
and Drs. C. Bucci, R. Fattouh, B. Finlay, J.-P. Gorvel, T. Johansen,
S. Pfeffer, I. Samjoo, and R. Valdivia for generously providing bacterial
strains, constructs, and helpful advice. We also thank Mike Woodside,
Paul Paroutis, Doug Holmyard, and Robert Tempkin for help with micro-
scopy and Ms. Linhua Zhang for cloning the constructs used for structure
determination. The Canadian Light Source is supported by the Natural Sci-
ences and Engineering Research Council of Canada, the National Research
Council Canada, the Canadian Institutes of Health Research (CIHR), the
Province of Saskatchewan, Western Economic Diversification Canada, and
the University of Saskatchewan. J.H.B. was supported by an Investigators
in Pathogenesis of Infectious Disease Award from the Burroughs Wellcome
Fund. The infrastructure for the J.H.B. laboratory was provided by a New
Opportunities Fund from the Canadian Foundation for Innovation and the
Ontario Innovation Trust. V.B. was supported by the Ontario Post Doctoral
Fellowship from the Ministry of Research and Innovation and the University
of Toronto. J.H.B. holds the Pitblado Chair in Cell Biology at the Hospital for
Sick Children. V.M.D. was supported by a Banting Fellowship from theCell ReCIHR. This work was supported by operating grants from the CIHR (MOP
#62890, #93634, and GSP-48370) and by the Canada Research Chairs pro-
gram (to M.C.).
Received: March 13, 2015
Revised: June 30, 2015
Accepted: July 29, 2015
Published: August 20, 2015
REFERENCES
Bakowski, M.A., Braun, V., Lam, G.Y., Yeung, T., Heo, W.D., Meyer, T., Finlay,
B.B., Grinstein, S., and Brumell, J.H. (2010). The phosphoinositide phospha-
tase SopB manipulates membrane surface charge and trafficking of the Sal-
monella-containing vacuole. Cell Host Microbe 7, 453–462.
Bertram, E.M., Hawley, R.G., and Watts, T.H. (2002). Overexpression of rab7
enhances the kinetics of antigen processing and presentation with MHC class
II molecules in B cells. Int. Immunol. 14, 309–318.
Brown, N.F., Szeto, J., Jiang, X., Coombes, B.K., Finlay, B.B., and Brumell,
J.H. (2006). Mutational analysis of Salmonella translocated effector members
SifA and SopD2 reveals domains implicated in translocation, subcellular local-
ization and function. Microbiology 152, 2323–2343.
Brumell, J.H., and Grinstein, S. (2004). Salmonella redirects phagosomal
maturation. Curr. Opin. Microbiol. 7, 78–84.
Brumell, J.H., Kujat-Choy, S., Brown, N.F., Vallance, B.A., Knodler, L.A., and
Finlay, B.B. (2003). SopD2 is a novel type III secreted effector of Salmonella ty-
phimurium that targets late endocytic compartments upon delivery into host
cells. Traffic 4, 36–48.
Buchmeier, N.A., and Heffron, F. (1991). Inhibition of macrophage phago-
some-lysosome fusion by Salmonella typhimurium. Infect. Immun. 59, 2232–
2238.
Burkinshaw, B.J., Prehna, G., Worrall, L.J., and Strynadka, N.C. (2012). Struc-
ture of Salmonella effector protein SopB N-terminal domain in complex with
host Rho GTPase Cdc42. J. Biol. Chem. 287, 13348–13355.
Cantalupo, G., Alifano, P., Roberti, V., Bruni, C.B., and Bucci, C. (2001). Rab-
interacting lysosomal protein (RILP): the Rab7 effector required for transport to
lysosomes. EMBO J. 20, 683–693.
Cheminay, C., Mo¨hlenbrink, A., and Hensel, M. (2005). Intracellular Salmonella
inhibit antigen presentation by dendritic cells. J. Immunol. 174, 2892–2899.
Feng, Y., Press, B., and Wandinger-Ness, A. (1995). Rab 7: an important regu-
lator of late endocytic membrane traffic. J. Cell Biol. 131, 1435–1452.
Figueira, R., and Holden, D.W. (2012). Functions of the Salmonella pathoge-
nicity island 2 (SPI-2) type III secretion system effectors. Microbiology 158,
1147–1161.
Garcia-del Portillo, F., Zwick, M.B., Leung, K.Y., and Finlay, B.B. (1993). Sal-
monella induces the formation of filamentous structures containing lysosomal
membrane glycoproteins in epithelial cells. Proc. Natl. Acad. Sci. USA 90,
10544–10548.
Halici, S., Zenk, S.F., Jantsch, J., and Hensel, M. (2008). Functional analysis of
the Salmonella pathogenicity island 2-mediated inhibition of antigen presenta-
tion in dendritic cells. Infect. Immun. 76, 4924–4933.
Huynh, K.K., Plumb, J.D., Downey, G.P., Valvano, M.A., and Grinstein, S.
(2010). Inactivation of macrophage Rab7 by Burkholderia cenocepacia.
J. Innate Immun. 2, 522–533.
Ingmundson, A., Delprato, A., Lambright, D.G., and Roy, C.R. (2007). Legion-
ella pneumophila proteins that regulate Rab1 membrane cycling. Nature 450,
365–369.
Ishibashi, Y., and Arai, T. (1990). Specific inhibition of phagosome-lysosome
fusion in murine macrophages mediated by Salmonella typhimurium infection.
FEMS Microbiol. Immunol. 2, 35–43.
Jackson, L.K., Nawabi, P., Hentea, C., Roark, E.A., and Haldar, K. (2008). The
Salmonella virulence protein SifA is a G protein antagonist. Proc. Natl. Acad.
Sci. USA 105, 14141–14146.ports 12, 1508–1518, September 1, 2015 ª2015 The Authors 1517
Jiang, X., Rossanese, O.W., Brown, N.F., Kujat-Choy, S., Gala´n, J.E., Finlay,
B.B., and Brumell, J.H. (2004). The related effector proteins SopD and
SopD2 from Salmonella enterica serovar Typhimurium contribute to virulence
during systemic infection of mice. Mol. Microbiol. 54, 1186–1198.
Jordens, I., Fernandez-Borja, M., Marsman, M., Dusseljee, S., Janssen, L.,
Calafat, J., Janssen, H., Wubbolts, R., and Neefjes, J. (2001). The Rab7
effector protein RILP controls lysosomal transport by inducing the recruitment
of dynein-dynactin motors. Curr. Biol. 11, 1680–1685.
Lamothe, J., Huynh, K.K., Grinstein, S., and Valvano, M.A. (2007). Intracellular
survival of Burkholderia cenocepacia in macrophages is associated with a
delay in the maturation of bacteria-containing vacuoles. Cell. Microbiol. 9,
40–53.
Machner, M.P., and Isberg, R.R. (2006). Targeting of host Rab GTPase func-
tion by the intravacuolar pathogen Legionella pneumophila. Dev. Cell 11,
47–56.
Machner, M.P., and Isberg, R.R. (2007). A bifunctional bacterial protein links
GDI displacement to Rab1 activation. Science 318, 974–977.
McGourty, K., Thurston, T.L., Matthews, S.A., Pinaud, L., Mota, L.J., and Hold-
en, D.W. (2012). Salmonella inhibits retrograde trafficking of mannose-6-phos-
phate receptors and lysosome function. Science 338, 963–967.
Mead, P.S., Slutsker, L., Dietz, V., McCaig, L.F., Bresee, J.S., Shapiro, C.,
Griffin, P.M., and Tauxe, R.V. (1999). Food-related illness and death in the
United States. Emerg. Infect. Dis. 5, 607–625.
Me´resse, S., Gorvel, J.P., and Chavrier, P. (1995). The rab7 GTPase resides on
a vesicular compartment connected to lysosomes. J. Cell Sci. 108, 3349–
3358.
Mu¨ller, M.P., Peters, H., Blu¨mer, J., Blankenfeldt, W., Goody, R.S., and Itzen,
A. (2010). The Legionella effector protein DrrA AMPylates themembrane traffic
regulator Rab1b. Science 329, 946–949.
Murata, T., Delprato, A., Ingmundson, A., Toomre, D.K., Lambright, D.G., and
Roy, C.R. (2006). The Legionella pneumophila effector protein DrrA is a Rab1
guanine nucleotide-exchange factor. Nat. Cell Biol. 8, 971–977.
Pankiv, S., Alemu, E.A., Brech, A., Bruun, J.A., Lamark, T., Overvatn, A., Bjør-
køy, G., and Johansen, T. (2010). FYCO1 is a Rab7 effector that binds to LC31518 Cell Reports 12, 1508–1518, September 1, 2015 ª2015 The Auand PI3P to mediate microtubule plus end-directed vesicle transport. J. Cell
Biol. 188, 253–269.
Progida, C., Malerød, L., Stuffers, S., Brech, A., Bucci, C., and Stenmark, H.
(2007). RILP is required for the proper morphology and function of late endo-
somes. J. Cell Sci. 120, 3729–3737.
Schroeder, N., Mota, L.J., andMe´resse, S. (2011). Salmonella-induced tubular
networks. Trends Microbiol. 19, 268–277.
Seto, S., Matsumoto, S., Ohta, I., Tsujimura, K., and Koide, Y. (2009). Dissec-
tion of Rab7 localization on Mycobacterium tuberculosis phagosome. Bio-
chem. Biophys. Res. Commun. 387, 272–277.
Steele-Mortimer, O., Me´resse, S., Gorvel, J.P., Toh, B.H., and Finlay, B.B.
(1999). Biogenesis of Salmonella typhimurium-containing vacuoles in epithelial
cells involves interactions with the early endocytic pathway. Cell. Microbiol. 1,
33–49.
Stenmark, H. (2009). Rab GTPases as coordinators of vesicle traffic. Nat. Rev.
Mol. Cell Biol. 10, 513–525.
Szeto, J., Namolovan, A., Osborne, S.E., Coombes, B.K., and Brumell, J.H.
(2009). Salmonella-containing vacuoles display centrifugal movement associ-
ated with cell-to-cell transfer in epithelial cells. Infect. Immun. 77, 996–1007.
Uchiya, K., Barbieri, M.A., Funato, K., Shah, A.H., Stahl, P.D., and Groisman,
E.A. (1999). A Salmonella virulence protein that inhibits cellular trafficking.
EMBO J. 18, 3924–3933.
Wu, M., Wang, T., Loh, E., Hong, W., and Song, H. (2005). Structural basis for
recruitment of RILP by small GTPase Rab7. EMBO J. 24, 1491–1501.
Xu, X., and Hensel, M. (2010). Systematic analysis of the SsrAB virulon of Sal-
monella enterica. Infect. Immun. 78, 49–58.
Yu, D., and Kuipers, J.G. (2003). Role of bacteria and HLA-B27 in the patho-
genesis of reactive arthritis. Rheum. Dis. Clin. North Am. 29, 21–36, v–vi.
Yu, X.J., Ruiz-Albert, J., Unsworth, K.E., Garvis, S., Liu, M., and Holden, D.W.
(2002). SpiC is required for secretion of Salmonella Pathogenicity Island 2 type
III secretion system proteins. Cell. Microbiol. 4, 531–540.thors
